About PharOS
PharOS was established in 2002 in Metamorfosi, Greece, as a manufacturer and supplier within the pharmaceutical sector. Operations focus on the production and distribution of generic drugs, serving markets through established supply chains. The company is led by co-founder Stella Koukaki, with activities centered in Greece and supported by the domain pharosgr.gr for online presence. Core services include formulation, quality control, and regulatory compliance for generic medications.
- Headquarter Metamorfosi, Greece
- Founders Stella Koukaki
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of PharOS
Unlock access to complete
Unlock access to complete
Funding Insights of PharOS
Investors in PharOS
PharOS has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include DECA Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward SMEs in Greece.
|
Locked | Locked | Locked |
Investor details for PharOS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharOS
Investment portfolio details for PharOS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PharOS
Detailed financials for PharOS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharos Comparisons
Peer comparison for PharOS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PharOS
Detailed competitors of PharOS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharos
Complete news archive for PharOS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharOS
PharOS was founded in 2002 and raised its 1st funding round 17 years after it was founded.
PharOS is headquartered in Metamorfosi, Greece. It is registered at Metamorfosi, Attica, Greece.
PharOS was established in 2002 in Metamorfosi, Greece, as a manufacturer and supplier within the pharmaceutical sector. Operations focus on the production and distribution of generic drugs, serving markets through established supply chains. The company is led by co-founder Stella Koukaki, with activities centered in Greece and supported by the domain pharosgr.gr for online presence. Core services include formulation, quality control, and regulatory compliance for generic medications.
PharOS has 1 investor. Key investors include DECA Investments.